|
Volumn 3, Issue 3, 2001, Pages 150-153
|
Modulating sensitivity to drug-induces apoptosis: The future for chemotherapy?
|
Author keywords
Apoptosis; Drug resistance; MEK; Paclitaxel
|
Indexed keywords
1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE;
2 (2 AMINO 3 METHOXYPHENYL)CHROMONE;
2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE;
ANTINEOPLASTIC AGENT;
MITOGEN ACTIVATED PROTEIN KINASE;
MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;
MITOGEN ACTIVATED PROTEIN KINASE KINASE;
PACLITAXEL;
PROTEIN SERINE THREONINE KINASE;
ADJUVANT THERAPY;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
APOPTOSIS;
CANCER;
CANCER CHEMOTHERAPY;
CELL DEATH;
CELL SURVIVAL;
CONTROLLED STUDY;
DRUG POTENTIATION;
DRUG RESISTANCE;
DRUG SENSITIVITY;
DRUG TARGETING;
EMBRYO;
HUMAN;
MOUSE;
NONHUMAN;
NOTE;
PROTEIN FAMILY;
PUBLICATION;
RAT;
SIGNAL TRANSDUCTION;
ANTINEOPLASTIC AGENTS, PHYTOGENIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
CELL CYCLE;
DRUG RESISTANCE;
ENZYME INHIBITORS;
FLAVONOIDS;
GENES, DOMINANT;
HUMANS;
MITOGEN-ACTIVATED PROTEIN KINASE KINASES;
MITOGEN-ACTIVATED PROTEIN KINASES;
NEOPLASMS;
PACLITAXEL;
|
EID: 0035034537
PISSN: 14655411
EISSN: None
Source Type: Journal
DOI: 10.1186/bcr289 Document Type: Note |
Times cited : (46)
|
References (25)
|